Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,744 total articles
Gwenn Hansen, the Chief Scientific Officer at Nurix Therapeutics, Inc. (NASDAQ:NRIX), conducted a series of transactions involving company common stock on April 30, 2026. These actions included the sale of 3,214 shares to meet tax withholding requirements and the acquisition of 8,608 shares through the vesting of restricted stock units (RSUs). Foll…
Anika Therapeutics, Inc. (NASDAQ: ANIK) President and CEO Stephen D. Griffin has increased his direct ownership in the company through a recent open-market transaction. The acquisition occurred on April 30, 2026, totaling $149,880 for 12,200 shares of common stock. This move follows a period of downward pressure on the company's share price, which …
Forager Fund, L.P., a significant stakeholder holding a ten percent interest in Regional Management Corp. (RM), has completed a series of stock sales totaling approximately $195,444. The divestment took place over a two-day period in late April 2026, involving the disposal of 5,017 shares of common stock at various price points.
Jason P. Rhodes, a director at Dyne Therapeutics, Inc. (NASDAQ: DYN), has completed a significant sale of common stock totaling approximately $4,178,516. The transaction involved 227,337 shares sold on April 28, 2026, within a price range of $18.00 to $19.00 per share. This divestment occurred through a pre-established Rule 10b5-1 trading plan adop…
Shantanu Narayen, the Chair and Chief Executive Officer of Adobe Inc., has completed a significant sale of company stock totaling more than $18 million. According to recent SEC Form 4 filings, the transactions involved 75,000 shares of Adobe common stock (NASDAQ: ADBE) on April 28, 2026. These sales were conducted indirectly through The Narayen Fam…
Jeffrey J. Brown, a member of the board of directors at Upbound Group, Inc. (NYSE:UPBD), has increased his position in the company through multiple transaction types totaling over $45,000 in common stock. These acquisitions occurred on April 28, 2026, and coincide with a period of varied financial performance for the firm, which recently reported e…
George Djurasovic, serving as the Interim General Counsel for Principal Financial Group Inc. (NASDAQ: PFG), has completed two transactions involving the sale of company common stock. The total value of these disposals reached approximately $259,332 during late April 2026. These sales occur against a backdrop of recent positive financial reporting a…
Richard N. Nottenburg, a member of the Board of Directors at Applied Digital Corp. (NASDAQ: APLD), has completed the sale of 25,000 shares of common stock. The transactions, which represent a total value of $832,375, were disclosed in a recent Form 4 filing with the Securities and Exchange Commission. The sales took place over two days at the end o…
Joey B. Hogan, a director for Covenant Logistics Group, Inc. (NASDAQ:CVLG), recently completed a sale of company stock totaling roughly $510,927. The transaction, which took place on April 28, 2026, involved the disposal of 14,700 shares of Class A Common Stock. This movement comes at a time when the company's stock is trading near its 52-week peak…
Peter Rahmer, the Chief Corporate Development Officer at Relay Therapeutics, Inc. (NASDAQ: RLAY), has completed a sale of company common stock. The transaction occurred on April 28, 2026, involving the disposal of 753 shares at a price point of $14.79 per share. This movement resulted in total proceeds of $11,136.The sale was not a discretionary ma…
George K. Ng, serving as both the Chief Executive Officer and a Director of Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), has completed a purchase of common stock in the company. The transaction, which took place on March 31, 2026, involved the acquisition of 2,136 shares at a price point of $2.535 per share, representing a total investment value …
David L. Finkelstein, serving as CEO and Co-CIO of Annaly Capital Management Inc., has completed a sale of 50,000 shares of common stock. The transaction, valued at approximately $1,144,000, occurred on April 27, 2026. This divestment was executed through a Rule 10b5-1 trading plan established on May 16, 2024, specifically intended for estate and t…
Caroline Alting, who serves as the Senior Vice President of Operations Excellence & Sustainability at Noble Corp plc (NYSE: NE), has completed a sale of her company stock. The transaction involved 15,340 A Ordinary Shares, executed on April 28, 2026. This move comes during a period of significant price appreciation for Noble Corp, as the stock rece…
Owlet, Inc. (NASDAQ: OWLT) Chief Financial Officer Amanda Crawford has reported a series of stock sales totaling $112,794. The transactions, which involved the sale of 11,705 shares, occurred at varying price points ranging from $3.20 to $11.50 per share. These disposals were non-discretionary in nature, executed through automatic processes designe…
Martin Roper, the Chief Executive Officer of Vita Coco Company, Inc. (NASDAQ:COCO), has completed a series of stock transactions totaling approximately $2.5 million. The sales occurred over a two-day period in late April 2026, involving 45,544 shares of common stock. These disposals took place against a backdrop of intense upward momentum for the c…
Exzeo Group, Inc. (NASDAQ: XZO) has seen notable insider activity following a recent filing with the Securities and Exchange Commission. Chief Executive Officer Paresh Patel executed a direct purchase of common stock, adding to his existing holdings. This transaction occurs against a backdrop of recent share price volatility, as the company's stock…
Thomas Catinazzo, the Chief Financial Officer of Relay Therapeutics, Inc. (NASDAQ: RLAY), has completed a sale of company common stock. The transaction, valued at $14,375, occurred on April 28, 2026. The shares were sold at a price point of $14.79 per share, which represents a premium compared to the current trading level of $12.96.The sale involve…
Andrew Callos, the Executive Vice President and Chief Commercial Officer of Cytokinetics Inc (NASDAQ:CYTK), has completed a transaction involving the sale of company stock. The sale occurred on April 30, 2026, immediately following the exercise of non-qualified stock options. This activity takes place amid a period of significant clinical focus for…
Joseph S. Galli, a member of the Board of Directors at BV Financial, Inc. (NASDAQ: BVFL), has completed a sale of common stock held through an individual retirement account (IRA). The transaction, which occurred on April 28, 2026, involved the disposal of 5,992 shares for a total consideration of $120,751. This movement comes as the company's stock…
Ruth T. Dowling, who serves as the Executive Vice President, Chief Administrative Officer, General Counsel, and Secretary for American Tower Corp (NYSE: AMT), has completed two transactions involving the sale of company common stock. The total value of the shares sold reached $173,091. These transactions took place in late April 2026, occurring at …
Opaleye Management Inc., a major stakeholder holding a ten percent ownership position in SANUWAVE Health, Inc. (NASDAQ: SNWV), has completed a series of stock sales totaling approximately $1.27 million. The transactions, which were carried out over two consecutive days on April 28 and April 29, 2026, took place amidst a period of notable price vola…
Visa Inc. (NYSE:V) Chief Executive Officer Ryan McInerney has completed a significant sale of company stock. On April 29, 2026, McInerney sold 31,455 shares of Visa’s Class A Common Stock for an aggregate value of $10,699,204. The transaction was conducted through a Rule 10b5-1 trading plan that had been put in place on May 15, 2025.This divestment…
James O. Donnelly, the President and Chief Executive Officer of Norwood Financial Corp. (NASDAQ: NWFL), has expanded his indirect position in the company through a recent stock purchase. On April 29, 2026, Donnelly acquired 100 shares of common stock at a price of $29.06 per share, representing a total transaction value of $2,906. This specific acq…
Cormorant Asset Management, LP, alongside its affiliate Cormorant Global Healthcare Master Fund, LP and Bihua Chen, executed a significant sale of common stock in Bright Minds Biosciences Inc. (NASDAQ: DRUG). The transaction, which took place on April 28, 2026, involved the disposal of 109,331 shares at an average price of $89.5 per share. This liq…
A recent regulatory filing with the Securities and Exchange Commission has revealed that Michelle R. Cassabaum, a director at Ames National Corp (NASDAQ: ATLO), has increased her position in the company through a purchase of common stock. The transaction, which occurred on April 30, 2026, involved the acquisition of 84 shares at a price point of $2…
